Showing results (371-380 of 392) with videos related to

Sort By:
Pageof 40
Cancer|July 8, 2020
Impact of optimizing diagnostic workup and reducing the time to treatment in head and neck cancerHenrieke W Schutte, Guido B van den Broek, Stefan C A Steens, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 22, 2020
Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [68Ga]Ga-DOTA-E-[c(RGDfK)]2 PET/CTD Lobeek, M Rijpkema, S Y A Terry, et al.
Head & Neck|August 11, 2016
Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adultsEline Boon, Winette T A van der Graaf, Hans Gelderblom, et al.
Clinical Nutrition (Edinburgh, Scotland)|December 9, 2021
Development and external validation of a prediction model for tube feeding dependency for at least four weeks during chemoradiotherapy for head and neck cancerAnna C H Willemsen, Annemieke Kok, Laura W J Baijens, et al.
The Lancet Regional Health. Europe|March 11, 2024
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access ProtocolKarlijn Verkerk, Birgit S Geurts, Laurien J Zeverijn, et al.
International Journal of Cancer|March 2, 2018
A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The NetherlandsEline Boon, Miranda Bel, Wim van Boxtel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2019
Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinomaSarah R Verhoeff, Suzanne C van Es, Eline Boon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 10, 2019
[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancerE J van Helden, S G Elias, S L Gerritse, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 27, 2024
DNA Methylation Profiling of Salivary Gland Tumors Supports and Expands Conventional ClassificationPhilipp Jurmeister, Maximilian Leitheiser, Alexander Arnold, et al.
The Lancet. Oncology|August 1, 2017
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysisBenjamin Lacas, Jean Bourhis, Jens Overgaard, et al.
Pageof 40